Max Brenner1, Teresina Laragione, Adriana Mello, Pércio S Gulko. 1. Laboratory of Experimental Rheumatology, The Robert S Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, 350 Community Drive, Room 139, Manhasset, NY 11030, USA.
Abstract
BACKGROUND: A genomewide scan in a DA x ACI F2 intercross studied for collagen-induced arthritis (CIA) identified the severity quantitative trait locus Cia25 on rat chromosome 12. Cia25 co-localises with loci regulating several forms of autoimmune diseases in rats, mice and humans, suggesting a common gene. OBJECTIVE: To characterise the effects of Cia25 on severity of arthritis in congenic rats. METHODS: DA.ACI(Cia25) congenic rats were constructed according to a genotype-guided strategy, and tested for pristane-induced arthritis (PIA) and CIA, induced with rat type II collagen (CII). A well-established scoring system previously shown to correlate with histological damage, including cartilage and bone erosions, synovial hyperplasia and synovial inflammation, was used. RESULTS: The introgression of ACI alleles at Cia25 into DA background, as in DA.ACI(Cia25) rats, was enough to significantly reduce arthritis severity by 60% in PIA and by 40% in CIA, both in males and females compared with DA rats of the same sex. Levels of IgG anti-CII in male DA.ACI(Cia25) rats were 83% lower than in male DA. Levels of anti-CII in females were not affected by the congenic interval. CONCLUSIONS: Cia25 contains a gene that regulates disease severity in two distinct models of autoimmune arthritis. Although both genders were protected in arthritis studies, only male congenic rats had a dramatic reduction in levels of anti-CII, suggesting the possibility of a second arthritis gene in this interval that operates via the regulation of autoantibodies in a sex-specific manner. The identification of the gene(s) accounting for Cia25 is expected to generate novel prognostic biomarkers and targets for therapy.
BACKGROUND: A genomewide scan in a DA x ACI F2 intercross studied for collagen-induced arthritis (CIA) identified the severity quantitative trait locus Cia25 on rat chromosome 12. Cia25 co-localises with loci regulating several forms of autoimmune diseases in rats, mice and humans, suggesting a common gene. OBJECTIVE: To characterise the effects of Cia25 on severity of arthritis in congenic rats. METHODS: DA.ACI(Cia25) congenic rats were constructed according to a genotype-guided strategy, and tested for pristane-induced arthritis (PIA) and CIA, induced with rat type II collagen (CII). A well-established scoring system previously shown to correlate with histological damage, including cartilage and bone erosions, synovial hyperplasia and synovial inflammation, was used. RESULTS: The introgression of ACI alleles at Cia25 into DA background, as in DA.ACI(Cia25) rats, was enough to significantly reduce arthritis severity by 60% in PIA and by 40% in CIA, both in males and females compared with DA rats of the same sex. Levels of IgG anti-CII in male DA.ACI(Cia25) rats were 83% lower than in male DA. Levels of anti-CII in females were not affected by the congenic interval. CONCLUSIONS:Cia25 contains a gene that regulates disease severity in two distinct models of autoimmune arthritis. Although both genders were protected in arthritis studies, only male congenic rats had a dramatic reduction in levels of anti-CII, suggesting the possibility of a second arthritis gene in this interval that operates via the regulation of autoantibodies in a sex-specific manner. The identification of the gene(s) accounting for Cia25 is expected to generate novel prognostic biomarkers and targets for therapy.
Authors: Carol J Etzel; Wei V Chen; Neil Shepard; Damini Jawaheer; Francois Cornelis; Michael F Seldin; Peter K Gregersen; Christopher I Amos Journal: Hum Genet Date: 2006-04-13 Impact factor: 4.132
Authors: D Jawaheer; M F Seldin; C I Amos; W V Chen; R Shigeta; J Monteiro; M Kern; L A Criswell; S Albani; J L Nelson; D O Clegg; R Pope; H W Schroeder ; S L Bridges ; D S Pisetsky; R Ward; D L Kastner; R L Wilder; T Pincus; L F Callahan; D Flemming; M H Wener; P K Gregersen Journal: Am J Hum Genet Date: 2001-03-09 Impact factor: 11.025
Authors: P M Gaffney; W A Ortmann; S A Selby; K B Shark; T C Ockenden; K E Rohlf; N L Walgrave; W P Boyum; M L Malmgren; M E Miller; G M Kearns; R P Messner; R A King; S S Rich; T W Behrens Journal: Am J Hum Genet Date: 2000-02 Impact factor: 11.025
Authors: M M Griffiths; J Wang; B Joe; S Dracheva; Y Kawahito; J S Shepard; V R Reese; S McCall-Vining; A Hashiramoto; G W Cannon; E F Remmers; R L Wilder Journal: Arthritis Rheum Date: 2000-06
Authors: B Joe; E F Remmers; D E Dobbins; J L Salstrom; T Furuya; S Dracheva; P S Gulko; G W Cannon; M M Griffiths; R L Wilder Journal: Immunogenetics Date: 2000-09 Impact factor: 2.846
Authors: T Furuya; J L Salstrom; S McCall-Vining; G W Cannon; B Joe; E F Remmers; M M Griffiths; R L Wilder Journal: Hum Mol Genet Date: 2000-09-22 Impact factor: 6.150
Authors: Elaine F Remmers; Bina Joe; Marie M Griffiths; David E Dobbins; Svetlana V Dracheva; Akira Hashiramoto; Takefumi Furuya; Jennifer L Salstrom; JianPing Wang; Pércio S Gulko; Grant W Cannon; Ronald L Wilder Journal: Arthritis Rheum Date: 2002-08
Authors: Jonatan Tuncel; Sabrina Haag; Markus H Hoffmann; Anthony C Y Yau; Malin Hultqvist; Peter Olofsson; Johan Bäcklund; Kutty Selva Nandakumar; Daniela Weidner; Anita Fischer; Anna Leichsenring; Franziska Lange; Claus Haase; Shemin Lu; Percio S Gulko; Günter Steiner; Rikard Holmdahl Journal: PLoS One Date: 2016-05-26 Impact factor: 3.240